Literature DB >> 2475523

Comparison of conventional staining methods and monoclonal antibody-based methods for Cryptosporidium oocyst detection.

M J Arrowood1, C R Sterling.   

Abstract

The sensitivity and specificity of seven microscopy-based Cryptosporidium oocyst detection methods were compared after application to unconcentrated fecal smears. The seven methods were as follows: (i) a commercial acid-fast (AF) stain (VOLU-SOL) method, (ii) Truant auramine-rhodamine (AR) stain method, (iii) fluorescein-conjugated C1B3 monoclonal antibody (MAb) direct fluorescence method, (iv) OW3 MAb indirect fluorescence method, (v) biotinylated OW3 indirect fluorescence method, (vi) biotinylated OW3-indirect diaminobenzidine (DAB) method, and (vii) biotinylated OW3-aminoethylcarbazole (AEC) method. A total of 281 randomly collected Formalin-fixed fecal samples (submitted to the Maricopa County Health Department, Phoenix, Ariz.) and 30 known positives (Formalin-fixed and K2Cr2O7-preserved stools from our laboratory) were examined in a blind test; 32 of 311 samples (10.3%) were confirmed positive. Of the confirmed positives, 40.6% were identified by the AF method, 93.8% were identified by the AR method, 93.8% were identified by the C1B3 method, 81.3% were identified by the OW3-DAB method, 71.9% were identified by the OW3-AEC method, 100% were identified by the OW3 indirect fluorescence method, and 100% were identified by the biotinylated OW3 indirect fluorescence method. False-positives were encountered by the AF and AR methods (52.0 and 85.7% specificity, respectively), while no false-positives encountered by the MAb-based methods. Oocysts in infected tissue sections were easily detected by the MAb-based methods.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475523      PMCID: PMC267601          DOI: 10.1128/jcm.27.7.1490-1495.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients.

Authors:  M J Arrowood; C R Sterling
Journal:  J Parasitol       Date:  1987-04       Impact factor: 1.276

2.  Cryptosporidia detection.

Authors:  R Lumb; J Erlich; G P Davidson
Journal:  Med J Aust       Date:  1985-03-04       Impact factor: 7.738

3.  Staining of faecal yeasts and cryptosporidium oocysts.

Authors:  K W Angus; I Campbell; E W Gray; D Sherwood
Journal:  Vet Rec       Date:  1981-02-21       Impact factor: 2.695

4.  Identification of cryptosporidium oocysts by monoclonal antibody.

Authors:  J McLauchlin; D P Casemore; T G Harrison; P J Gerson; D Samuel; A G Taylor
Journal:  Lancet       Date:  1987-01-03       Impact factor: 79.321

5.  Concentration and identification of Cryptosporidium sp. by use of a parasite concentrator.

Authors:  W S Zierdt
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

6.  The species of Cryptosporidium (Apicomplexa: Cryptosporidiidae) infecting mammals.

Authors:  S J Upton; W L Current
Journal:  J Parasitol       Date:  1985-10       Impact factor: 1.276

7.  Fluorescence detection of Cryptosporidium oocysts in human fecal specimens by using monoclonal antibodies.

Authors:  L S Garcia; T C Brewer; D A Bruckner
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

8.  The purification of mouse monoclonal antibodies from ascitic fluid.

Authors:  S H Neoh; C Gordon; A Potter; H Zola
Journal:  J Immunol Methods       Date:  1986-07-24       Impact factor: 2.303

9.  Antigens of Cryptosporidium sporozoites recognized by immune sera of infected animals and humans.

Authors:  J R Mead; M J Arrowood; C R Sterling
Journal:  J Parasitol       Date:  1988-02       Impact factor: 1.276

10.  Field inversion gel electrophoretic separation of Cryptosporidium spp. chromosome-sized DNA.

Authors:  J R Mead; M J Arrowood; W L Current; C R Sterling
Journal:  J Parasitol       Date:  1988-06       Impact factor: 1.276

View more
  36 in total

1.  Improved stool concentration procedure for detection of Cryptosporidium oocysts in fecal specimens.

Authors:  R Weber; R T Bryan; D D Juranek
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  Effectiveness of dehydroepiandrosterone in reduction of cryptosporidial activity in immunosuppressed rats.

Authors:  K R Rasmussen; M J Arrowood; M C Healey
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Detection of Cryptosporidium parvum in soil extracts.

Authors:  Mark Walker; Douglas Redelman
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

4.  ACP Broadsheet 128: June 1991. Laboratory methods for diagnosing cryptosporidiosis.

Authors:  D P Casemore
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

Review 5.  Epidemiological aspects of human cryptosporidiosis.

Authors:  D P Casemore
Journal:  Epidemiol Infect       Date:  1990-02       Impact factor: 2.451

6.  Detection of Cryptosporidium parvum in horses: thresholds of acid-fast stain, immunofluorescence assay, and flow cytometry.

Authors:  D J Cole; K Snowden; N D Cohen; R Smith
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

Review 7.  Detection of infection or infectious agents by use of cytologic and histologic stains.

Authors:  G L Woods; D H Walker
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

8.  Prevalence of Cryptosporidium in children with enteritis in southern Italy.

Authors:  O Brandonisio; A Marangi; M A Panaro; R Marzio; M I Natalicchio; P Zizzadoro; U De Santis
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

9.  Experimental Cryptosporidium parvum infections in immunosuppressed adult mice.

Authors:  K R Rasmussen; M C Healey
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Enteric Pathogens in HIV/AIDS from a Tertiary Care Hospital.

Authors:  Beena Uppal; Bineeta Kashyap; Preena Bhalla
Journal:  Indian J Community Med       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.